- •
Identifying patients with heart failure who are at high risk for poor outcomes is important for patient care, resource allocation and process improvement.
- •
Several risk models exist to identify high-risk patients with heart failure, based on traditional statistical risk modeling methodology.
- •
Risk models for heart failure are infrequently used in practice because of their modest performance outside validation cohorts, lack of evidence to support that risk modeling in heart failure improves
Predicting High-Risk Patients and High-Risk Outcomes in Heart Failure
Section snippets
Key points
Established risk factors for poor outcomes in patients with heart failure
Several demographic and clinical variables have been explored as markers of increased risk for adverse outcomes in HF populations. Risk factors can vary substantially based on the outcome of interest or the population under study. Although a discussion of all of these risk factors is beyond the scope of this article, some of the prognostic features that have been consistently found to be significant drivers of clinically important outcomes, including mortality, hospitalization, and
Multivariable risk models for patients with heart failure
Considerable effort has been devoted to developing multivariable risk scores to help summarize and simplify risk assessment so that it can be performed in real time in a clinical setting or embedded into systems of care. To date, hundreds of multivariable risk scores for predicting outcomes in HF populations have been developed. Most of these risk models have been derived from multivariable statistical modeling, such as logistic regression (LR) and Cox proportional hazards analysis. Some of
Lack of evidence for clinical utility of risk prediction models
The literature is teeming with HF risk prediction models; however, there is little evidence that incorporating risk prediction into clinical practice influences management or improves outcomes. Model development for the sake of prediction has become a popular educational hobby,47 but, in order for risk models to be used to improve processes of care, they should be interpretable and actionable. Most models include risk factors that are not modifiable (eg, age) and it is unclear what, if any,
Barriers to implementation of risk prediction models in clinical practice and systems of care
Despite all of the efforts to develop a well-validated risk prediction model for patients with HF, adoption of risk modeling to assess prognosis in clinical settings is low. Less than 1% of patients enrolled in a long-term HF registry were offered information regarding prognosis calculated from a risk model by their treating clinicians.18 One major reason for this is likely the lack of evidence for the clinical utility of implementation of HF risk scores; however, there are also several
Promise of artificial intelligence for risk prediction in heart failure
Rapid advances in computational power, the digital big data revolution, and innovations in mathematical algorithms have led to a recent resurgence of enthusiasm surrounding the utility of artificial intelligence in several industries. The recent popularity of artificial intelligence has been propelled by the development of novel machine learning (ML) models, which are computer algorithms designed to learn without explicit programming, instead relying on patterns and inference from data (Fig. 1
Summary and future directions
Predicting outcomes in patients with HF has proved difficult. Although many individual risk factors for adverse future outcomes are known, attempts at developing high-performing risk models in various HF populations using statistically based methods have generally underwhelming. Moreover, there is currently a lack of evidence to support the notion that implementation of these risk scores into clinical practice or systems of care improves outcomes. Newer methods of risk prediction using ML
Disclosure
S.J. Shah is supported by grants from the National Institutes of Health (R01 HL140731, R01 HL120728, R01 HL107577, and R01 HL149423); the American Heart Association (#16SFRN28780016, #15CVGPSD27260148); Actelion, AstraZeneca, Corvia, and Novartis; and has received consulting fees from Actelion, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Cardiora, Eisai, Ionis, Ironwood, Merck, Novartis, Pfizer, Sanofi, and United Therapeutics. F.S. Ahmad is supported in part by a grant from the Agency for
References (145)
- et al.
Triage after hospitalization with advanced heart failure. The ESCAPE (evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness) risk model and discharge score
J Am Coll Cardiol
(2010) - et al.
Risk score–guided multidisciplinary team-based Care for Heart Failure Inpatients is associated with lower 30-day readmission and lower 30-day mortality
Am Heart J
(2020) - et al.
Influence of predictive modeling in implementing optimal heart failure therapy
Am J Med Sci
(2011) - et al.
Risk stratification after hospitalization for decompensated heart failure
J Card Fail
(2004) - et al.
External model validation of binary clinical risk prediction models in cardiovascular and thoracic surgery
J Thorac Cardiovasc Surg
(2016) - et al.
Risk prediction in patients with heart failure: A systematic review and analysis
JACC Hear Fail
(2014) - et al.
Factors influencing the predictive power of models for predicting mortality and/or heart failure hospitalization inpatients with heart failure
JACC Hear Fail
(2014) - et al.
Performance of prognostic risk scores in chronic heart failure patients enrolled in the european society of cardiology heart failure long-term registry
JACC Hear Fail
(2018) - et al.
Recognizing hospitalized heart failure as an entity and developing new therapies to improve outcomes. academics’, clinicians’, industry’s, regulators’, and payers’ perspectives
Heart Fail Clin
(2013) - et al.
Meta-analysis of risks for short-term readmission in patients with heart failure
Am J Cardiol
(2016)
Predictors of in-hospital mortality in patients hospitalized for heart failure. insights from the organized program to initiate lifesaving treatment in hospitalized patients with heart failure (OPTIMIZE-HF)
J Am Coll Cardiol
Predictors of mortality after discharge in patients hospitalized with heart failure: An analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)
Am Heart J
Epidemiology of hospitalized heart failure. differences and similarities between patients with reduced versus preserved ejection fraction
Heart Fail Clin
Precipitating clinical factors, heart failure characterization, and outcomes in patients hospitalized with heart failure with reduced, borderline, and preserved ejection fraction
JACC Hear Fail
Multidisciplinary strategies for the management of heart failure patients at high risk for admission: A systematic review of randomized trials
J Am Coll Cardiol
Results of the chronic heart failure intervention to improve medication adherence study: A randomized intervention in high-risk patients
Am Heart J
A systematic review of randomized trials of disease management programs in heart failure
Am J Med
Prediction of rehospitalization and death in severe heart failure by physicians and nurses of the ESCAPE trial
J Card Fail
Clinical implications of chronic heart failure phenotypes defined by cluster analysis
J Am Coll Cardiol
Clinical characteristics and outcomes of young and very young adults with heart failure: The CHARM programme (candesartan in heart failure assessment of reduction in mortality and morbidity)
J Am Coll Cardiol
Sex and gender-related issues in heart failure
Heart Fail Clin
Disparities in cardiovascular mortality related to heart failure in the United States
J Am Coll Cardiol
Natural history of dilated cardiomyopathy due to lamin A/C gene mutations
J Am Coll Cardiol
Wide variation in clinicians’ assessment of New York Heart Association/World Health Organization functional class in patients with pulmonary arterial hypertension
Mayo Clin Proc
INTERMACS profiles of advanced heart failure: the current picture
J Heart Lung Transplant
Cardiac cachexia revisited: the role of wasting in heart failure
Heart Fail Clin
Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) trials and registry
Am J Cardiol
Heart failure and liver disease: cardiohepatic interactions
JACC Hear Fail
The cardiorenal syndrome in heart failure
Heart Fail Clin
Minding the gap in heart failure. Understanding the pulse pressure in reduced versus preserved ejection fraction
JACC Hear Fail
Correlates of early hospital readmission or death in patients with congestive heart failure
Am J Cardiol
The association between blood pressure and mortality in patients with heart failure
Am Heart J
Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial
Lancet
Atrial fibrillation in heart failure: focus on antithrombotic management
Heart Fail Clin
Heart Disease and Stroke Statistics-2020 Update A Report From the American Heart Association
Circulation
2013 ACCF/AHA guideline for the management of heart failure: A report of the american college of cardiology foundation/american heart association task force on practice guidelines
Circulation
Forecasting the impact of heart failure in the united states a policy statement from the american heart association
Circ Heart Fail
Risk stratification for in-hospital mortality in acutely decompensated heart failure: Classification and regression tree analysis
J Am Med Assoc
A validated risk score for in-hospital mortality in patients with heart failure from the American heart association get with the guidelines program
Circ Cardiovasc Qual Outcomes
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): The TRIPOD Statement
Ann Intern Med
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): Explanation and elaboration
Ann Intern Med
Cardiovascular risk prediction: Basic concepts, current status, and future directions
Circulation
Evaluating risk prediction models for adults with heart failure: A systematic literature review
PLoS One
Risk prediction models for mortality in ambulatory patients with heart failure a systematic review
Circ Heart Fail
The Seattle heart failure model: prediction of survival in heart failure
Circulation
Effect of amlodipine on morbidity and mortality in severe chronic heart failure
N Engl J Med
Use of risk models to predict death in the next year among individual ambulatory patients with heart failure
JAMA Cardiol
Predicting survival in heart failure: A risk score based on 39 372 patients from 30 studies
Eur Heart J
Predicting survival in heart failure: Validation of the MAGGIC heart failure risk score in 51 043 patients from the Swedish Heart Failure Registry
Eur J Heart Fail
Meta-analysis global group in chronic (MAGGIC) heart failure risk score: Validation of a simple tool for the prediction of morbidity and mortality in heart failure with preserved ejection fraction
J Am Heart Assoc
Cited by (18)
Personalizing Risk Assessment for Sudden Cardiac Death in Heart Failure: A Dream or a Reality?
2023, JACC: Heart FailureA Call to Move From Point-in-Time Toward Comprehensive Dynamic Risk Prediction in Critically Ill Patients With Heart Failure
2022, Journal of Cardiac FailureAdvances in Machine Learning Approaches to Heart Failure with Preserved Ejection Fraction
2022, Heart Failure ClinicsCitation Excerpt :Although most risk models for patients with HFpEF were developed in cohorts with all types of HF, there are a few models developed specifically for patients with HFpEF (such as the I-PRESERVE Score and ARIC Score).19 Most models have modest discrimination and calibration at best.19 ML has the potential to lead to the development of either higher performing models using more diverse data sources (ie, EHR, imaging, ECG, sensors) or a more parsimonious set of variables that will facilitate deployment with EHR systems.
Risk stratification models for predicting mortality in heart failure: a favourite or an outsider?
2024, European Journal of Preventive Cardiology